The use of Virtual Reality (VR) pain psychology therapy to relieve chronic pain associated with cancer.

Not Applicable

• Conditions: Chronic cancer-related pain; Anaesthesiology - Pain management; Cancer - Any cancer

• Registration Number: ACTRN12620000309987
• Lead Sponsor: A/Prof Alwin Chuan

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-03-05
• Last Update Posted: 10 March 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Adult (greater than or equal to 18yo) patients with cancer, and with the following characteristics:
- Eastern Cooperative Oncology Group (ECOG) score 0-2
- Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) score greater than or equal to 12

Exclusion Criteria

- Insufficient written English language proficiency to complete questionnaires.
- Insufficient verbal English language proficiency to interact with the VR software avatar.
- Psychological or psychiatric illness not stabilised with therapy and/or medications.
- Uncertainty or unable to be followed up for subsequent six months after recruitment

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Acceptability and feasibility endpoint will be assessed by a questionnaire. The questionnaire will ask about the three most commonly known side-effects of VR use: nausea, dizziness, and eyestrain. Patients will score using a 1-10 Visual Analogue Scale on the presence and severity of any of these side-effects. A free text box will be included for extra information or feedback not captured by the questions[Before and after each of the three VR sessions. ]